Managing Partner and Chairman
- bart.bergstein@forbion.com
- Download vCard 
Bart is Managing Partner and Chairman at Forbion Capital Partners. He founded ABN AMRO Capital Life Sciences in 2000 and co-founded Forbion Capital Partners in 2006.
He started his career in 1990 with ABN AMRO Bank, where he enjoyed an international career in commercial banking. In 1997 he joined the ABN AMRO Private Equity department. Bart was responsible for the first Life Sciences investments and expanded the team until the fund was spun out in 2006 into Forbion Capital Partners.
Bart has built a strong and diversified investment team and contributes operational and commercial experience to team and the portfolio companies.
Bart holds board seats at AM Pharma, Cytheris, Cellnovo and BioConnection. He is a Board member of the Mibiton Foundation, a government backed fund that supports the Dutch biotech industry with financing for lab equipment and infrastructure.
Earlier, Bart was on the Board of Rhein Biotech (IPO 1999) and Ubisys, an antibody company that later merged with Introgene into Crucell (IPO 2000).
Bart holds a degree in Construction Engineering from Eindhoven Technical University.
